8-K

RCM TECHNOLOGIES, INC. (RCMT)

8-K 2022-08-10 For: 2022-07-02
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 10, 2022

RCM Technologies, Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada<br><br> <br>(State or Other<br><br> <br>Jurisdiction of<br><br> <br>Incorporation) 1-10245<br><br> <br>(Commission File<br><br> <br>Number) 95-1480559<br><br> <br>(I.R.S. Employer<br><br> <br>Identification No.)
2500 McClellan Avenue, Suite 350
--- ---
Pennsauken, NJ 08109-4613
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (856) 356-4500

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)).

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.05 per share RCMT The NASDAQ Stock Market LLC

Item 2.02.       Results of Operations and Financial Condition.

On August 10, 2022, the Registrant issued a press release regarding its financial results for the thirteen and twenty-six weeks ended July 2, 2022.  A copy of the press release is furnished as Exhibit 99 to this report.

The information set forth under this “Item 2.02. Results of Operations and Financial Condition” (including the exhibit) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Registrant pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto.

Item 9.01.       Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

None.

(b) Pro Forma Financial Information.

None.

(c) Shell Company Transactions.

None.

(d) Exhibits.

Exhibit Number
99 Press Release by the Registrant, dated August 10, 2022, furnished in accordance with Item 2.02 of this Current Report on Form 8-K.
104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RCM TECHNOLOGIES, INC.

By: /s/ Kevin D. Miller
Kevin D. Miller
Chief Financial Officer, Treasurer and<br><br> <br>Secretary

Dated: August 10, 2022

ex_406752.htm

Exhibit 99

rcm01.jpg

RCM Technologies, Inc. Tel: 856.356.4500 Corporate Contacts:
2500 McClellan Avenue Fax: 856.356.4600 Bradley S. Vizi
Pennsauken, NJ 08109 info@rcmt.com Executive Chairman
www.rcmt.com Kevin D. Miller
Chief Financial Officer

P R E S S   R E L E A S E

RCM TECHNOLOGIES, INC. ANNOUNCES

SECOND-QUARTER RESULTS

Pennsauken, NJ – August 10, 2022 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and twenty-six weeks ended July 2, 2022.

RCM Technologies reported revenue of $74.3 million for the thirteen weeks ended July 2, 2022 (the current period), an increase of 51.9% compared to $48.9 million for the thirteen weeks ended July 3, 2021 (the comparable prior-year period). Gross profit was $21.7 million for the current period, a 76.8% increase compared to $12.3 million for the comparable prior-year period.  The Company experienced GAAP operating income of $8.2 million for the current period compared to $1.9 million for the comparable prior-year period.  The Company experienced GAAP net income of $6.0 million, or $0.57 per diluted share, for the current period compared to $1.3 million, or $0.11 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA of $8.4 million for the current period compared to $2.2 million for the comparable prior-year period.

RCM Technologies reported revenue of $156.3 million for the twenty-six weeks ended July 2, 2022 (the current period), an increase of 67.2% compared to $93.5 million for the twenty-six weeks ended July 3, 2021 (the comparable prior-year period). Gross profit was $45.1 million for the current period, a 95.1% increase compared to $23.1 million for the comparable prior-year period.  The Company experienced GAAP operating income of $17.2 million for the current period compared to $3.3 million for the comparable prior-year period.  The Company experienced GAAP net income of $12.5 million, or $1.18 per diluted share, for the current period compared to $2.3 million, or $0.19 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA of $17.7 million for the current period compared to $3.9 million for the comparable prior-year period.

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “I am pleased to announce strong performance throughout the company as we continue to make progress against our long-term strategy. Each unit demonstrated strong execution and performed well in our primarily recession-resistant end markets as demonstrated by year-over-year second-quarter increases of 281% for adjusted EBITDA and 418% for diluted EPS.”

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “After considering seasonal school closures, our second quarter revenue was consistent with trends experienced in our record-setting first quarter. In addition, we generated operating cash flow of $18.3 million in the second quarter and $20.8 million year-to-date. We anticipate we will continue to see strong results for the balance of fiscal 2022, and now intend to focus on delivering robust growth in fiscal 2023.”


Conference Call

On Thursday, August 11, 2022, RCM Technologies will host a conference call to discuss these results. The call will begin at 11:30 a.m. Eastern Time. The dial-in number is (866) 403-9129.

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. **** RCM is an innovative leader in delivering these solutions to commercial and government sectors. RCM is also a **** provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America and Serbia. Additional information can be found at www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to the impact of the COVID-19 pandemic, demand for the Company’s services, expectations regarding our future revenues and other financial results, our pipeline, and potential project wins, and our expectations for growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow


RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Per Share Amounts)

Thirteen Weeks Ended
July 2, 2022 July 3, 2021
Revenue 74,346 $48,933
Cost of services 52,663 36,667
Gross profit 21,683 12,266
Selling, general and administrative 13,264 10,005
Depreciation and amortization of property and equipment 225 259
Amortization of acquired intangible assets - 9
Operating income 8,194 1,943
Other (income) expense, net (28 201
Income before income taxes 8,222 1,742
Income tax expense 2,208 486
Net income 6,014 $1,256
Diluted net earnings per share data 0.57 $0.11

All values are in US Dollars.

Twenty-Six Weeks Ended
July 2, 2022 July 3, 2021
Revenue $156,307 $93,482
Cost of services 111,204 70,366
Gross profit 45,103 23,116
Selling, general and administrative 27,411 19,184
Depreciation and amortization of property and equipment 463 525
Amortization of acquired intangible assets - 89
Operating income 17,229 3,318
Other expense, net 24 213
Income before income taxes 17,205 3,105
Income tax expense 4,671 842
Net income $12,534 $2,263
Diluted net earnings per share data $1.18 $0.19

RCM Technologies, Inc.

Summary Consolidated Selected Balance Sheet Data

(In Thousands)

July 2,<br><br> <br>2022 January 1,<br><br> <br>2022
(Unaudited)
Cash and cash equivalents $3,112 $235
Accounts receivable, net $45,275 $48,240
Total current assets $51,541 $51,971
Total assets $72,425 $72,852
Total current liabilities $33,764 $29,857
Borrowings under line of credit $0 $14,151
Total liabilities $36,133 $46,883
Stockholders’ equity $36,292 $25,969

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“EBITDA” and “Adjusted EBITDA”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  EBITDA and Adjusted EBITDA should not be considered an alternative to net income as an indicator of performance.  In addition, EBITDA and Adjusted EBITDA do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP net income and the corresponding adjustments used to calculate EBITDA and Adjusted EBITDA for the thirteen and twenty-six weeks ended July 2, 2022 and July 3, 2021.

Thirteen Weeks Ended Twenty-Six Weeks Ended
July 2,<br> 2022 July 3,<br><br> <br>2021 July 2,<br> 2022 July 3,<br> 2021
GAAP net income 6,014 $1,256 12,534 2,263
Income tax expense 2,208 486 4,671 842
Interest expense 69 122 166 243
Change in fair value of contingent consideration - 26 - 52
Depreciation of property and equipment 225 259 463 525
Amortization of acquired intangible assets - 9 - 89
EBITDA (non-GAAP) 8,516 $2,158 17,834 4,014
Adjustments
(Gain) loss on foreign currency transactions (97 53 (142 (82
Adjusted EBITDA (non-GAAP) 8,419 $2,211 17,692 3,932

All values are in US Dollars.


RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

Thirteen Weeks Ended July 2, 2022
Engineering Specialty<br> Health Care Information<br> Technology Consolidated
Revenue 20,906 43,457 9,983 74,346
Cost of services 15,395 30,575 6,693 52,663
Gross profit 5,511 12,882 3,290 21,683
Gross profit margin 26.4 29.6 33.0 29.2

All values are in US Dollars.

Thirteen Weeks Ended July 3, 2021
Engineering Specialty<br> Health Care Information<br> Technology Consolidated
Revenue 16,934 22,941 9,058 48,933
Cost of services 12,920 17,349 6,398 36,677
Gross profit 4,014 5,592 2,660 12,266
Gross profit margin 23.7 24.4 29.4 25.1

All values are in US Dollars.

Twenty-Six Weeks Ended July 2, 2022
Engineering Specialty<br> Health Care Information<br> Technology Consolidated
Revenue 40,804 95,641 19,862 156,307
Cost of services 30,059 67,758 13,387 111,204
Gross profit 10,745 27,883 6,475 45,103
Gross profit margin 26.3 29.2 32.6 28.9

All values are in US Dollars.

Twenty-Six Weeks Ended July 3, 2021
Engineering Specialty<br> Health Care Information<br> Technology Consolidated
Revenue 31,400 44,077 18,005 93,482
Cost of services 24,180 33,448 12,738 70,366
Gross profit 7,220 10,629 5,267 23,116
Gross profit margin 23.0 24.1 29.3 24.7

All values are in US Dollars.


RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

Thirteen Weeks Ended
July 2,<br> 2022 July 3,<br> 2021
Net income 6,014 1,256
Adjustments to reconcile net income to cash<br><br> <br>used in operating activities 449 1,356
Changes in operating assets and liabilities:
Accounts receivable 13,779 8,059
Prepaid expenses and other current assets 343 1,178
Net of transit accounts receivable and payable (731 1,681
Accounts payable and accrued expenses 389 1,616
Accrued payroll and related costs (2,392 (248
Right of use liabilities (382 (489
Income taxes payable 1,111 93
Deferred revenue (315 913
Deposits 9 6
Total adjustments 12,260 14,165
Net cash provided by operating activities 18,274 15,421
Net cash used in investing activities (223 (123
Net cash used in financing activities (15,563 (14,639
Effect of exchange rate changes (235 62
Increase in cash and cash equivalents 2,253 721

All values are in US Dollars.

Twenty-Six Weeks Ended
July 2,<br> 2022 July 3,<br> 2021
Net income 12,534 2,263
Adjustments to reconcile net income to cash<br><br> <br>used in operating activities 1,186 2,533
Changes in operating assets and liabilities:
Accounts receivable 3,565 (1,066
Prepaid expenses and other current assets 434 1,676
Net of transit accounts receivable and payable (210 (121
Accounts payable and accrued expenses (585 1,663
Accrued payroll and related costs 3,048 (231
Right of use liabilities (926 (988
Income taxes payable 2,935 8
Deferred revenue (1,237 578
Deposits 11 6
Total adjustments 8,221 4,058
Net cash provided by operating activities 20,755 6,321
Net cash used in investing activities (453 (182
Net cash used in financing activities (17,175 (5,424
Effect of exchange rate changes (250 (50
Increase in cash and cash equivalents 2,877 665

All values are in US Dollars.